Peer Exchange

Experts in blood disorders share the importance of managing red blood cell health and optimal approaches and unmet needs in the management of sickle cell disease.

Experts in dermatology discuss treatment considerations for pediatric patients with atopic dermatitis and highlight emerging therapeutics andthe role they are likely to play in the future treatment of this condition.

Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.

A multidisciplinary panel of experts explores recent advances in the management of opioid induced constipation.

Retina specialists explore the practical and clinical implications of the rapidly developing treatment spectrum for diabetic macular edema and age-related macular degeneration.

Experts in pediatric hepatology share considerations for the diagnosis of Alagille syndrome and explore strategies for optimizing treatment.

Expert gastroenterologists examine the sequencing of therapies and optimizing treatment selection in the evolving treatment landscape for ulcerative colitis.

Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.

A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.

Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.

Experts in endocrinology and cardiology discuss various guideline and treatments for the management of ASCVD and hypercholesterolemia.

A panel of experts discusses vitiligo, its impact on the quality of life, and the role of shared-decision making in managing the disease. Panelists discuss their approach to setting patient expectations and share their enthusiasm about ongoing vitiligo research and therapies on the horizon.

A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.

Key opinion leaders explore the diagnosis, management, and treatment of attention deficit hyperactivity disorder (ADHD) in the adult population and share key insights on the evolving treatment landscape.

A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.

Expert panelists reflect on the selection and use of recently approved treatments, including interleukin pathway inhibitors, for type 2 inflammation in atopic dermatitis.

A panel of experts explore the impact of sickle cell disease on patients and discuss treatment and management considerations.

A panel of experts discuss their knowledge and experiences treating patients with psoriatic arthritis.

A panel of eye care specialists provide insight on the diagnosis, clinical manifestations, and treatment options for patients who have wet AMD.

Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.

A panel of experts discusses the clinical management of diabetic macular edema and the available and upcoming treatment options.

Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.

Anthony M. Turkiewicz, MD; Leonard H. Calabrese, DO; Sheetal Desai, MD; and Ana-Maria Orbai, MD, MHS, share insight on currently available biologic therapies, diagnostic strategies, and real-world case scenarios of psoriatic arthritis.

Key insight from a panel of retinal disease specialists on the role of VEGF inhibitors in managing retinal diseases, including non-proliferative diabetic retinopathy.

Expert panelists review novel agents and best practices that have improved the treatment landscape of atopic dermatitis.

An overview of treatment advances for atopic dermatitis and the role of the nurse practitioner and physician assistant in educating patients on treatment options and helping them gain access to more novel approaches.

Experts provide an overview on the management of inflammatory bowel disease using biologics and discussing their safety and efficacy data presented at the DDW Virtual 2021.

Expert panelists provide a lively discussion on currently available pharmacologic and non-pharmacologic treatment approaches in the management of hypoglycemic episodes in patients with diabetes.

A panel discussion focused on advances in the management of treatment-resistant depression and the fundamentals of certified treatment centers for the dispensing and administration of esketamine.